Ameriprise Financial Inc Palatin Technologies Inc Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$0.68 - $1.25 $26,198 - $48,158	-38,527 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$0.38 - $0.78 $14,640 - $30,051	38,527 New	38,527 $26,000
Q1 2019 May 15, 2019	SELL	$0.67 - $1.01 $32,428 - $48,884	-48,400 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $30,492 - $48,400	48,400 New	48,400 $34,000
Q1 2018 May 15, 2018	SELL	$0.84 - $1.18 $10,500 - $14,750	-12,500 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$0.68 - $1.0 $1,360 - $2,000	-2,000 Reduced 13.79%	12,500 $11,000
Q3 2017 Nov 07, 2017	BUY	$0.39 - $0.66 $5,655 - $9,570	14,500	14,500 $10,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.92M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.